December 11, 2018 09:35 AM EST
Bioregnum
Opinion

Fresh­man law­mak­ers give J&J CEO Alex Gorsky an­oth­er un­want­ed turn in the pub­lic spot­light

Over the last 46 years, the Har­vard Kennedy School’s In­sti­tute of Pol­i­tics has host­ed a gath­er­ing of new­ly elect­ed mem­bers of the House — from both …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times